Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN5 | P54829 | 2/20 | 0.39 |
| ▸ | PDE2A | O00408 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 2/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22242853 | 0.78 | PTPN5 (0.47) | PTPN5PDE2ACYP2D6CYP2C9HIF1A | |
| Lithium Ion SCHEMBL930658 | 0.77 | TSHR (0.44) | ALDH1A1IDO1KIF11 | |
| SCHEMBL16586837 | 0.74 | TSHR (0.46) | ALDH1A1IDO1KIF11 | |
| SCHEMBL16105865 | 0.70 | ESR1 (0.50) | PTPN5PDE2ACYP2D6CYP2C9HIF1A | |
| SCHEMBL14706850 | 0.70 | PTPN5 (0.47) | PTPN5PDE2ACYP2D6CYP2C9HIF1A | |
| SCHEMBL24408943 | 0.70 | PTPN5 (0.47) | PTPN5PDE2ACYP2D6CYP2C9HIF1A | |
| SCHEMBL84043 | 0.69 | PDE2A (0.53) | PTPN5PDE2ACYP2D6CYP2C9HIF1A | |
| SCHEMBL12887210 | 0.69 | PDE2A (0.48) | PTPN5PDE2ACYP2D6CYP2C9HIF1A | |
| SCHEMBL10189311 | 0.69 | PDE2A (0.70) | PTPN5PDE2ACYP2D6CYP2C9HIF1A | |
| SCHEMBL14997533 | 0.69 | PDE2A (0.48) | PTPN5PDE2ACYP2D6CYP2C9HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7868107-B2 | Process for producing cycloolefin addition polymer, catalyst for addition polymerization of cycloolefin, and transition metal compound | ZEON CORPORATION (JP) | 2011-01-11 | — | — | US | disclosed |
| US-20090124769-A1 | e.g. copolymerization of dicyclopentadiene with ethylene in presence of (t-butylamide)dimethyl-9-[octamethyloctahydrobenzofluorenyl]silanetitanium dimethyl(tetrahydrofuran) complex catalyst; exhibits high activity for both of addition homopolymerization of a cycloolefin and copolymerization with olefin | ZEON CORPORATION (JP) | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124769-A1 | e.g. copolymerization of dicyclopentadiene with ethylene in presence of (t-butylamide)dimethyl-9-[octamethyloctahydrobenzofluorenyl]silanetitanium dimethyl(tetrahydrofuran) complex catalyst; exhibits high activity for both of addition homopolymerization of a cycloolefin and copolymerization with olefin | ETFB, DDT, ETFA | PTPN5 4429/4885PDE2A 4752/4885CYP2D6 427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.